Dr. Thanh K Dang, MD Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 1500 Curve Crest Blvd W, Stillwater, MN 55082 Phone: 651-439-1234 Fax: 651-275-3325 |
Dr. Donna Marie Koning, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 1500 Curve Crest Blvd W, Stillwater, MN 55082 Phone: 651-439-1234 Fax: 651-275-3325 |
Erin Carlson, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 1500 Curve Crest Blvd W, Stillwater, MN 55082 Phone: 651-439-1234 Fax: 651-275-3325 |
Dr. Patrick R Stokes, MD Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 1875 Northwestern Ave S, Stillwater, MN 55082 Phone: 651-439-4840 Fax: 651-439-4894 |
Winfried Raabe, MD Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 1500 Curve Crest Blvd W, Stillwater, MN 55082 Phone: 651-439-1234 Fax: 651-439-1547 |
News Archive
Aeterna Zentaris Inc. today announced that a poster on its novel orally active anticancer Erk inhibitor, which includes AEZS-131, was presented at the 242nd American Chemical Society National Meeting held at the Colorado Convention Center in Denver, Colorado.
Five Prime Therapeutics, Inc. today announced it received a milestone payment from Centocor Research & Development, Inc. for the selection of a therapeutic that will be pursued for immunology-related indications. Under the collaboration, FivePrime identified multiple potential therapeutic targets through screening its comprehensive proprietary protein library in cell-based assays that were focused on therapeutic pathways underlying specific immune and inflammatory disorders.
The Utah Arts Council today announced it has selected Faces of Mali, an exhibit of photographs of village life in western Africa, for its 2010 traveling art program. The show, sponsored by Sorenson Molecular Genealogy Foundation (SMGF) and Mali Rising—two Utah-based non-profit organizations—and the Embassy of Mali, opens a window for viewers into a region with a 600-year history as a center for scholarship and trade. The first traveling exhibit is scheduled for Canyon Community Center in Springdale beginning Feb. 4.
ArQule, Inc. today announced the presentation of Phase 1 results of a clinical trial among patients with metastatic colorectal cancer (CRC) treated with ARQ 197, a selective small molecule inhibitor of the c-MET receptor tyrosine kinase, in combination with irinotecan and cetuximab. ARQ 197 is under development by Daiichi Sankyo Co., Ltd. and ArQule.
A new study published online in the journal Emerging Infectious Diseases describes the appearance of a new protozoan infection carried by insects which causes symptoms that mimic the disease called visceral leishmaniasis, caused by a different parasite.
› Verified 9 days ago